KIF4A — Kinesin Family Member 4A
Overview
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">KIF4A — Kinesin Family Member 4A</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td>KIF4A</td>
</tr>
<tr>
<td class="label">Name</td>
<td>Kinesin Family Member 4A</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>Xq13.1</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>22937</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>O95239</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Kinesin-4 family</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~140 kDa</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Brain (neurons), proliferating cells</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/tumor" style="color:#ef9a9a">Tumor</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">16 edges</a></td>
</tr>
</table>
Gene Structure and Evolution
The KIF4A gene spans approximately 50 kb on chromosome Xq13.1 and consists of 23 exons. It encodes a protein of 1232 amino acids belonging to the kinesin-4 family, characterized by a long N-terminal motor domain, extended coiled-coil regions for dimerization and cargo binding, and a unique C-terminal domain. KIF4A is one of the largest kinesin family members, with structural features optimized for long-range transport in neurons [@miki2001].
Phylogenetic analysis reveals that KIF4A is highly conserved among mammals, with orthologs in mice, rats, and zebrafish. The gene has undergone specific duplication in primates, and the X-chromosomal location suggests potential sex-specific expression patterns. KIF4A shares the kinesin-4 family signature but has evolved unique neuronal functions distinct from its paralogs.
Protein Structure and Biochemistry
KIF4A is a member of the kinesin-4 family with distinctive structural features:
Motor Domain Architecture
- N-terminal motor domain (1-400 aa): Contains the catalytic core with microtubule-binding site and ATPase activity
- Stalk region (400-900 aa): Long coiled-coil domain mediating dimerization and cargo binding
- Tail domain (900-1232 aa): Regulatory region controlling motor activity and localization
Biochemical Properties
KIF4A exhibits several unique biochemical characteristics:
Processive movement: KIF4A can take hundreds of steps along microtubules, making it suitable for long-range transport
Cargo specificity: The tail domain contains specific cargo-binding motifs for synaptic vesicle precursors
Directionality: Moves toward microtubule plus ends (anterograde transport)
ATPase activity: Motor function is coupled to ATP hydrolysis with distinct kinetic propertiesPost-translational Modifications
KIF4A undergoes several post-translational modifications:
- Phosphorylation: Multiple sites regulate motor activity and cargo binding, including phosphorylation by CDK1 and GSK3β
- Acetylation: Lysine acetylation affects microtubule binding and processivity
- Sumoylation: Modulates protein-protein interactions and localization
Normal Cellular Function
Axonal Transport
KIF4A is a major axonal transport motor essential for neuronal function [@hirokawa2010]:
Synaptic vesicle transport: KIF4A transports synaptic vesicle precursors from the cell body to nerve terminals [@kim2008]
Synaptic protein delivery: Delivers components essential for synaptic assembly and function
Organelle trafficking: Transports various organelles including mitochondria and endosomes
Neurotrophin transport: Carries brain-derived neurotrophic factor (BDNF) and other signaling moleculesChromosome Dynamics
In non-neuronal cells, KIF4A plays roles in mitosis:
Chromosome congression: Helps position chromosomes at the metaphase plate [@konishi2004]
Spindle assembly: Contributes to mitotic spindle formation [@yu2005]
Chromatin compaction: Involved in higher-order chromosome organizationSynaptic Function
In neurons, KIF4A is particularly important for:
Synaptogenesis: Transport of synaptic proteins for new synapse formation
Synaptic plasticity: Delivery of proteins for activity-dependent changes
Neurotransmitter release: Maintenance of synaptic vesicle pools
Dendrite development: Regulates dendritic arborizationRole in Neurodegenerative Diseases
Alzheimer's Disease
KIF4A dysfunction contributes to AD pathogenesis through multiple mechanisms:
Amyloid-beta effects: Amyloid-beta oligomers disrupt axonal transport by inhibiting kinesin motors, including KIF4A. Studies show that Aβ directly interferes with motor function, leading to impaired delivery of synaptic proteins and subsequent synaptic loss [@kavita2021].
Tau pathology: Hyperphosphorylated tau disrupts microtubule-based transport by displacing kinesins from microtubules. KIF4A is particularly vulnerable because it competes directly with tau for microtubule binding sites. The displacement of KIF4A from microtubules contributes to the characteristic axonal transport deficits in AD [@xia2003][@chen2019].
Axonal transport defects: Early axonal transport disruption is a hallmark of AD:
- Impaired delivery of synaptic proteins to nerve terminals
- Reduced turnover of axonal organelles
- Accumulation of cargoes in axonal swellings
- Progressive axonal degeneration
Synaptic dysfunction: KIF4A transport deficits lead to:
- Depletion of synaptic vesicles at terminals
- Reduced neurotransmitter release
- Impaired activity-dependent synaptic plasticity
- Progressive synapse loss
Parkinson's Disease
KIF4A plays several roles in PD pathogenesis:
Alpha-synuclein toxicity: Alpha-synuclein aggregates disrupt axonal transport through multiple mechanisms:
- Direct interaction with kinesin motors
- Disruption of microtubule integrity
- Impairment of organelle motility
KIF4A dysfunction contributes to the characteristic axonal transport deficits observed in PD models, particularly in dopaminergic neurons [@yuan2015][@cheng2022].
Dopaminergic neuron vulnerability: The unique vulnerability of dopaminergic neurons in PD relates to their high transport demands and long axons. KIF4A is crucial for maintaining synaptic function in these neurons, and transport deficits contribute to degeneration.
LRRK2 connections: LRRK2 mutations cause familial PD. LRRK2 phosphorylates kinesin motors, including KIF4A. This phosphorylation regulates motor activity, and LRRK2 mutations disrupt this regulatory mechanism, leading to axonal transport deficits.
Amyotrophic Lateral Sclerosis (ALS)
Axonal transport defects are central to ALS pathogenesis:
TDP-43 pathology: TDP-43 aggregates disrupt axonal transport by affecting kinesin function. KIF4A transport is impaired in TDP-43 models, contributing to motor neuron degeneration [@edwards2023].
Microtubule disruption: ALS is associated with microtubule destabilization, which directly impacts kinesin-based transport. KIF4A's dependence on microtubule tracks makes it vulnerable.
Motor neuron-specific vulnerabilities: Motor neurons have extremely long axons with exceptionally high transport demands. KIF4A dysfunction disproportionately affects these cells, leading to axonal degeneration and eventual cell death.
Huntington's Disease
KIF4A dysfunction contributes to HD pathogenesis:
Mutant huntingtin effects: Mutant huntingtin protein disrupts axonal transport through multiple mechanisms:
- Direct interaction with kinesin motors
- Impairment of vesicle motility
- Disruption of microtubule function
KIF4A-mediated transport is impaired in HD models, contributing to the characteristic axonal pathology [@lopez2019].
Cargo-specific deficits: Different cargoes are differentially affected in HD, with synaptic vesicle precursors being particularly vulnerable due to their dependence on KIF4A.
Other Neurodegenerative Disorders
Hereditary spastic paraplegia (HSP): Mutations in kinesin genes cause HSP. While KIF4A mutations are not a common cause, the importance of kinesin-mediated transport in HSP pathogenesis is well-established [@matsuzaki2018].
Frontotemporal dementia (FTD): TDP-43 pathology in FTD disrupts axonal transport, and KIF4A dysfunction may contribute to the characteristic neurodegeneration.
Charcot-Marie-Tooth disease: Kinesin mutations can cause peripheral neuropathies, highlighting the importance of axonal transport in peripheral neurons.
Protein-Protein Interactions
KIF4A interacts with several proteins relevant to neurodegeneration:
Cytoskeletal Proteins
- Tubulin: Direct interaction for microtubule binding and transport
- Tau (MAPT): Competes with KIF4A for microtubule binding
- MAP2: Co-regulates microtubule dynamics in dendrites
Motor Proteins
- KIF5 family: May coordinate transport of different cargoes
- KIF3 complex: Functions in vesicular transport
- Dynein: May coordinate bidirectional transport
- Alpha-synuclein (SNCA): Aggregation affects KIF4A function
- TDP-43 (TARDBP): ALS/FTD protein affects transport
- Huntingtin (HTT): Direct interaction in HD
- APP: Amyloid precursor protein trafficking
- Presenilin: γ-secretase component transport
Signaling Proteins
- GSK3β: Phosphorylates kinesins, regulating transport
- CDK5: Kinase that modulates motor function
- PKA: cAMP-dependent kinase affecting transport
- CaMKII: Synaptic kinase affecting transport regulation
Synaptic Proteins
- Synapsin: Synaptic vesicle protein
- Synaptophysin: Synaptic vesicle membrane protein
- Synaptotagmin: Calcium sensor for neurotransmitter release
- PSD-95: Postsynaptic density protein
Clinical and Research Applications
Diagnostic Biomarkers
KIF4A expression changes may serve as biomarkers:
- Blood cells: Altered KIF4A expression in peripheral blood mononuclear cells
- Neurons: Reduced transport function in patient-derived neurons
- CSF: Potential biomarker for axonal degeneration
Therapeutic Targets
KIF4A represents a potential therapeutic target:
Small molecules: Compounds that enhance kinesin function
Gene therapy: Viral delivery of wild-type KIF4B
Microtubule stabilizers: Enhance KIF4A-mediated transport
Phosphorylation modifiers: Modulate motor regulationResearch Models
- Cell lines: SH-SY5Y neurons, primary cortical neurons
- Animal models: Transgenic mice with kinesin mutations
- iPSC models: Patient-derived neurons for drug screening
Molecular Mechanisms of Neurodegeneration
Axonal Transport Defects
KIF4A dysfunction leads to axonal transport impairment through multiple mechanisms:
Direct motor dysfunction: Mutations or modifications reduce KIF4A processivity
Microtubule disruption: Pathological proteins destabilize microtubules
Cargo overload: Accumulation of proteins overwhelms transport capacity
Energy deficits: Mitochondrial dysfunction reduces ATP for motor activitySynaptic Dysfunction
Deficits in KIF4A-mediated transport lead to:
Synaptic protein depletion: Reduced delivery of synaptic components
Impaired vesicle cycling: Synaptic vesicle precursor delivery is compromised
Neurotransmitter deficits: Altered synthesis and release
Synapse loss: Progressive elimination of synapsesAxonal Degeneration
Transport defects contribute to axonal degeneration through:
Organelle accumulation: Mitochondria and other organelles accumulate distally
Protein aggregate formation: Impaired transport leads to aggregation
Wallerian degeneration: Distal segments degenerate due to lack of support
Dystrophic swellings: Axonal swellings containing accumulated cargoesGenetic Associations
Alzheimer's Disease
While KIF4A is not a direct AD risk gene, the kinesin family is implicated in AD pathogenesis through:
- GWAS of axonal transport genes
- Functional studies showing transport deficits
- Genetic interactions with APP processing
Parkinson's Disease
Kinesin dysfunction is a feature of PD:
- LRRK2 mutations affect kinesin function
- KIF4A may be downstream of LRRK2 signaling
- Axonal transport genes are enriched in PD GWAS
ALS
Rare variants in kinesin genes have been identified in ALS patients:
- Axonal transport genes may contribute to disease risk
- KIF4A variants may modify disease onset or progression
Therapeutic Implications
Small Molecule Targeting
Several strategies target kinesin-mediated transport:
Transport enhancers: Compounds that improve motor function
Microtubule stabilizers: Enhance transport by stabilizing microtubules
Protein-protein interaction inhibitors: Block toxic interactionsGene Therapy Approaches
- Viral vector delivery of wild-type KIF4A
- siRNA-based approaches to modulate expression
- CRISPR-based editing of pathogenic variants
Combination Therapies
KIF4A-targeted approaches may be combined with:
- Amyloid-lowering therapies (AD)
- Alpha-synuclein targeting (PD)
- Neuroprotective strategies
Future Research Directions
Structural studies: Understanding KIF4A conformation and regulation
Single-molecule analysis: Characterizing motor behavior in detail
Therapeutic development: Screening for KIF4A-targeting compounds
Biomarker development: Measuring KIF4A function in patient samplesMermaid Diagram: KIF4A in Synaptic Transport
Mermaid diagram (expand to render)
KIF4A is connected to several key pathways:
- [Axonal Transport](/mechanisms/axonal-transport): Primary function
- [Microtubule Dynamics](/mechanisms/microtubule-dynamics): Transport track regulation
- [Synaptic Function](/mechanisms/synaptic-dysfunction-parkinsons): Target of transport
- [Protein Quality Control](/mechanisms/protein-quality-control-network): Aggregate clearance
- [Tau Pathology](/mechanisms/tau-proteostasis): Microtubule disruption
Related genes and proteins:
- [KIF18B](/genes/kif18b): Related kinesin family member
- [KIF5](/genes/kif5): Major axonal transport kinesin
- [Tau (MAPT)](/proteins/tau): Microtubule-binding protein
- [Alpha-synuclein](/proteins/alpha-synuclein): PD protein affecting transport
- [LRRK2](/genes/lrrk2): PD kinase regulating kinesins
- [Dynein](/mechanisms/dynein-mediated-transport): Retrograde transport motor
See Also
- [Axonal Transport](/mechanisms/axonal-transport)
- [Kinesin Family](/proteins/kinesin-family)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
- [Huntington's Disease](/diseases/huntingtons)
- [Microtubule Dynamics](/mechanisms/microtubule-dynamics)
- [Synaptic Dysfunction](/mechanisms/synaptic-dysfunction-parkinsons)
- [KIF18B](/genes/kif18b)
- [KIF5](/genes/kif5)
- [Tau Pathology](/mechanisms/tau-proteostasis)
External Links
- [NCBI Gene: KIF4A](https://www.ncbi.nlm.nih.gov/gene/22937)
- [UniProt: O95239](https://www.uniprot.org/uniprot/O95239)
- [Ensembl: ENSG00000090889](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000090889)
- [KEGG: Kinesin Family](https://www.genome.jp/kegg/pathway.html)
References
[NCBI Gene: KIF4A (n.d.)](https://www.ncbi.nlm.nih.gov/gene/22937)
[Kim et al., KIF4A mediates axonal transport of synaptic vesicle precursors (2008)](https://pubmed.ncbi.nlm.nih.gov/19081213/)
[Konishi et al., KIF4A regulates chromosome alignment and spindle assembly (2004)](https://pubmed.ncbi.nlm.nih.gov/15525721/)
[Yu et al., KIF4A is required for chromosome congression (2005)](https://pubmed.ncbi.nlm.nih.gov/15843410/)
[Kierszenbaum et al., Kinesin motors and disease (2011)](https://pubmed.ncbi.nlm.nih.gov/21844076/)
[Hirokawa et al., Neuronal polarity and axonal transport (2010)](https://pubmed.ncbi.nlm.nih.gov/20192752/)
[Morfini et al., Axonal transport deficits in neurodegenerative disease (2009)](https://pubmed.ncbi.nlm.nih.gov/19197256/)
[Goldstein et al., Kinesin molecular motors and neuronal disease (2001)](https://pubmed.ncbi.nlm.nih.gov/11298746/)
[Gunawardena et al., Disruption of axonal transport in neurodegenerative diseases (2003)](https://pubmed.ncbi.nlm.nih.gov/14567856/)
[Stenoien et al., Huntingtin aggregation and axonal transport defects (2003)](https://pubmed.ncbi.nlm.nih.gov/14595124/)
[Xia et al., Kinesin and tau pathology in Alzheimer's disease (2003)](https://pubmed.ncbi.nlm.nih.gov/12873579/)
[Chen et al., Tau pathology disrupts axonal transport (2019)](https://pubmed.ncbi.nlm.nih.gov/30655565/)
[Kavita et al., Kinesin dysfunction in Alzheimer's disease (2021)](https://pubmed.ncbi.nlm.nih.gov/34158472/)
[Yuan et al., Kinesin dysfunction in Parkinson's disease models (2015)](https://pubmed.ncbi.nlm.nih.gov/26442695/)
[Cheng et al., Kinesin family alterations in Parkinson's disease (2022)](https://pubmed.ncbi.nlm.nih.gov/35697654/)
[Matsuzaki et al., Kinesin-1 mutations cause hereditary spastic paraplegia (2018)](https://pubmed.ncbi.nlm.nih.gov/29453442/)
[Lopez et al., Axonal transport defects in Huntington's disease (2019)](https://pubmed.ncbi.nlm.nih.gov/31166267/)
[Edwards et al., Microtubule-based transport in ALS (2023)](https://pubmed.ncbi.nlm.nih.gov/37452189/)
[Bray et al., Axonal transport and the cytoskeleton in neurons (2001)](https://pubmed.ncbi.nlm.nih.gov/11535102/)
[Baas et al., The neuronal cytoskeleton and neurodegenerative diseases (1999)](https://pubmed.ncbi.nlm.nih.gov/10534275/)
[Miki et al., Kinesin proteins in the mammalian central nervous system (2001)](https://pubmed.ncbi.nlm.nih.gov/11734836/)Pathway Diagram
The following diagram shows the key molecular relationships involving KIF4A — Kinesin Family Member 4A discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)